Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Aurobindo Pharma
Pharmaceutical Preparation ManufacturingIndiaNSE: AUROPHARMA.NS
Last verified 9 months agoaurobindo.com
Aurobindo Pharma Limited, often referred to simply as Aurobindo, is a leading Indian multinational pharmaceutical manufacturing company. Headquartered in Hyderabad, India, it boasts a significant global footprint with operations spanning numerous countries worldwide.
Established in 1987, Aurobindo Pharma specialises in the production of high-quality pharmaceutical preparations. Their extensive portfolio encompasses active pharmaceutical ingredients (APIs), generics, and biosimilars, serving a broad range of therapeutic areas.
Renowned for its vertically integrated business model, Aurobindo excels in delivering affordable and accessible medicines. This strategic approach has cemented its position as a major player in the global pharmaceutical market, consistently contributing to healthcare innovation and accessibility.
46
DitchCarbon score
+4 vs industry average
Aurobindo Pharma’s score of 46 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Aurobindo Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Aurobindo Pharma's reported carbon emissions
Aurobindo Pharma, a Pharmaceutical Preparation Manufacturing company headquartered in India, has set climate commitments to reduce its carbon footprint.
For 2025, Aurobindo Pharma reported estimated total emissions of approximately 1.23 billion kg CO2e. This includes about 750.6 million kg CO2e for Scope 1 emissions, 474.8 million kg CO2e for Scope 2 emissions, and 360.2 million kg CO2e for Scope 3 emissions. Key contributors to Scope 3 emissions include fuel and energy-related activities (around 247 million kg CO2e) and downstream transportation and distribution (approximately 70.7 million kg CO2e).
In 2024, the company's total emissions were approximately 967.5 million kg CO2e, comprising around 414.4 million kg CO2e from Scope 1 and 553.1 million kg CO2e from Scope 2. For 2023, total emissions were about 941.5 million kg CO2e, with Scope 1 emissions at approximately 447.2 million kg CO2e and Scope 2 emissions at around 494.3 million kg CO2e. Looking back, in 2022, total emissions were approximately 858.9 million kg CO2e (Scope 1: about 361.6 million kg CO2e, Scope 2: approximately 497.3 million kg CO2e). In 2021, total emissions were around 903.4 million kg CO2e (Scope 1: approximately 359.4 million kg CO2e, Scope 2: about 544 million kg CO2e).
Aurobindo Pharma has committed to a near-term absolute reduction target for its carbon footprint. The company aims to achieve a 12.5% reduction in both Scope 1 and Scope 2 emissions by 2025, using 2020 as a baseline year. This target aligns with a "well below 2°C scenario" as per the Science Based Targets initiative (SBTi) framework.
Assessing Aurobindo Pharma as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Aurobindo Pharma and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Aurobindo Pharma’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
8 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
2025 disclosureSee details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Aurobindo Pharma9 months ago
46
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more